The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer

CONTEXT: Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis in need of more effective treatment options. Published evidence indicates many ACCs express the vascular endothelial growth factor receptor (VEGFR), suggesting inhibiting vascular endothelial growth factor signaling c...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: O'Sullivan, Ciara, Edgerly, Maureen, Velarde, Margarita, Wilkerson, Julia, Venkatesan, Aradhana M., Pittaluga, Stefania, Yang, Sherry X., Nguyen, Dat, Balasubramaniam, Sanjeeve, Fojo, Tito
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2014
Teme:
Endocrine Care
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3973787/
https://ncbi.nlm.nih.gov/pubmed/24423320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-2298
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items